Advertisement

Der Onkologe

, Volume 23, Issue 3, pp 196–200 | Cite as

Supportive Therapie Teil 2

Mikronährstoffe
  • R. MückeEmail author
  • B. Zomorodbakhsch
  • O. Micke
  • J. Büntzel
  • K. Kisters
  • I. A. Adamietz
  • K. Fakhrian
Leitthema
  • 359 Downloads

Zusammenfassung

Hintergrund

Unverändert besteht ein großes Interesse von Tumorpatienten an der zusätzlichen Einnahme von Mikronährstoffen zwecks Immunstabilisierung während der onkologischen Therapie. Im Gegensatz dazu bestehen gerade in Deutschland trotz Zunahme seriöser Daten diesbezüglich weiterhin Bedenken. Dieses Update liefert weitere Daten, den zusätzlichen Einsatz von ausgewählten Mikronährstoffen während der Tumortherapie in Erwägung zu ziehen.

Methoden

Es erfolgte eine Literaturrecherche hinsichtlich des Einsatzes von ausgewählten Mikronährstoffen in der Onkologie, die von 2013 bis 2016 in zitierfähigen Journalen erschienen sind.

Ergebnisse

Es werden Daten zu Vitamin D, Selen, Vitamin C, Glutamin und L‑Carnitin präsentiert, die sowohl hinsichtlich der Lebensqualität als auch der Prognose einen Nutzen für onkologische Patienten bringen.

Schlussfolgerung

Onkologisch tätige Ärzte sollten Kenntnisse über die wichtigsten Mikronährstoffe haben, um diese an die Patienten weiterzugeben und sie auch gezielt zum Nutzen der Patienten einzusetzen.

Schlüsselwörter

Mikronährstoffe Selen Vitamin D Vitamin C Glutamin L-Carnitin 

Supportive therapy part 2

Micronutrients

Abstract

Background

There is still a great deal of interest among cancer patients on the additional use of micronutrients in order to improve the quality of life during oncological therapy. In contrast, many German oncologists still reject the use of micronutrients during tumor therapy. This update provides additional data to consider the additional use of selected micronutrients during anticancer therapy.

Methods

A search of the  literature was carried out for articles on the use of selected micronutrients in oncology that were published between 2013 and 2016 in citable journals.

Results

Data on vitamin D, selenium, vitamin C, glutamine and L‑carnitine are presented in terms of quality of life and the prognosis for cancer patients.

Conclusion

Physicians should be able to provide well-informed advice to patients and in those cases where the evidence warrants it, integrate the use of specific micronutrients into the strategies of care.

Keywords

Micronutrients Selenium Vitamin D Vitamin C Glutamine L-carnitine 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

R. Mücke, B. Zomorodbakhsch, O. Micke, J. Büntzel, K. Kisters, I. A. Adamietz und K. Fakhrian geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Armenian SH, Gelehrter SK, Vase T et al (2014) Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines. Cancer Epidemiol Biomarkers Prev 23(6):1109–1114CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Bittenbring JT, Neumann F, Altmann B et al (2014) Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B‑cell lymphoma treated with but not without rituximab. J Clinoncol 32(29):3242–3248CrossRefGoogle Scholar
  3. 3.
    Chattopadhyay S, Saha A, Azam M et al (2014) Role of oral glutamine in alleviation and prevention of radiation-induced oralmucositis: a prospective randomized study. South Asian J Cancer 3(1):8–12CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Choi AR, Jo MJ, Jung MJ et al (2015) Selenate specifically sensitizes drug-resistant cancer cells by increasing apoptosis via G2 phase cell cycle arrest without P‑GP inhibition. Eur J Pharmacol 764:63–69CrossRefPubMedGoogle Scholar
  5. 5.
    Crowther MA, Avenell A, Culligan DJ (2009) Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation. Bone Marrow Transplant 44:413–425CrossRefPubMedGoogle Scholar
  6. 6.
    Fedirko V, Riboli E, Tjønneland A et al (2012) Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European populations. Cancer Epidemiol Biomarkers Prev 21(4):582–593CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Greenlee H, Balneaves LG, Carlson LE et al (2014) Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr 50:346–358CrossRefGoogle Scholar
  8. 8.
    Gröber U, Mücke R, Adamietz IA et al (2013) Komplementärer Einsatz von Antioxidanzien und Mikronährstoffen in der Onkologie. Onkologe 19:136–143CrossRefGoogle Scholar
  9. 9.
    Harris HR, Bergkvist L, Wolk A (2013) Vitamin C intake and breast cancer mortality in a cohort of Swedish women. Br J Cancer 109(1):257–264CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Harris HR, Orsini N, Wolk A (2014) Vitamin C and survival among women with breast cancer: a meta-analysis. Eur J Cancer 50(7):1223–1231CrossRefPubMedGoogle Scholar
  11. 11.
    Hoffmann MR, Senior PA, Mager DR (2015) Vitamin D supplementation and health-related quality of life: a systematic review of the literature. J Acad Nutr Diet 115(3):406–418CrossRefPubMedGoogle Scholar
  12. 12.
    Hooke MC, McCarthy K, Taylor O et al (2015) Fatigue and carnitine levels over multiple cycles of chemotherapy in children and adolescents. Eur J Oncol Nurs 19(1):7–12CrossRefPubMedGoogle Scholar
  13. 13.
    Jacobs C, Hutton B, Ng T et al (2015) Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. Oncologist 20(2):210–223CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Jolfaie NR, Mirzaie S, Ghiasvand R et al (2015) The effect of glutamine intake on complications of colorectal and colon cancer treatment: A systematic review. J Res Med Sci 20(9):910–918PubMedPubMedCentralGoogle Scholar
  15. 15.
    Karp DD, Lee SJ, Keller SM et al (2013) Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. J Clin Oncol 31(33):4179–4187CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Kenfield SA, Van Blarigan EL, DuPre N et al (2014) Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst 107(1):360CrossRefPubMedGoogle Scholar
  17. 17.
    Khan Q, Reddy PS, Kimler BF et al (2010) Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 119:111–118CrossRefPubMedGoogle Scholar
  18. 18.
    Lee S (2015) Mineral derivatives in alleviating oral mucositis during cancer therapy: a systematic review. PeerJ 12(3):e765CrossRefGoogle Scholar
  19. 19.
    Lohmann AE, Chapman JA, Burnell MJ et al (2015) Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer. Breast Cancer Res Treat 150(3):605–611CrossRefPubMedGoogle Scholar
  20. 20.
    Maalmi H, Ordóñez-Mena JM, Schöttker B et al (2014) Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Eur J Cancer 50(8):1510–1521CrossRefPubMedGoogle Scholar
  21. 21.
    Mix M, Ramnath N, Gomez J et al (2015a) Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer. World J Clinoncol 6(5):156–165Google Scholar
  22. 22.
    Mix M, Singh AK, Tills M et al (2015b) Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck. World J Clinoncol 6(5):166–173Google Scholar
  23. 23.
    Mohr SB, Gorham ED, Kim J et al (2015) Could vitamin D sufficiency improve the survival of colorectal cancer patients? J Steroid Biochem Mol Biol 148:239–244CrossRefPubMedGoogle Scholar
  24. 24.
    Muecke M, Mochamat Cuhls H, Peuckmann-Post V et al (2015) Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 5:CD006788. doi: 10.1002/14651858.cd006788.pub3 Google Scholar
  25. 25.
    Muecke R, Micke O, Schomburg L et al (2014) Multicenter, phase III trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization. Integr Cancer Ther 13(6):463–467CrossRefPubMedGoogle Scholar
  26. 26.
    Napoli N, Vattikuti S, Ma C et al (2010) High prevalence of low vitamin D and musculoskeletal complaints in women with breast cancer. Breast J 16:609–616CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Pilz S, Kienreich K, Tomaschitz A et al (2013) Vitamin D and cancer mortality: systematic review of prospective epidemiological studies. Anticancer Agents Med Chem 13(1):107–117CrossRefPubMedGoogle Scholar
  28. 28.
    Poole EM, Shu X, Caan BJ et al (2013) Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project. Breast Cancer Res Treat 139(2):529–537CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Puspitasari IM, Abdulah R, Yamazaki C et al (2014) Updates on clinicalstudiesofseleniumsupplementation in radiotherapy. RadiatOncol 9:125Google Scholar
  30. 30.
    Sayles C, Hickerson SC, Bhat RR et al (2016) Oral glutamine in preventing treatment-related mucositis in adult patients with cancer: a systematic review. Nutr Clin Pract 31:171–179CrossRefPubMedGoogle Scholar
  31. 31.
    Schloss JM, Colosimo M, Airey C, Masci PP, Linnane AW, Vitetta L (2013) Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review. Clin Nutr 32(6):888–893CrossRefPubMedGoogle Scholar
  32. 32.
    Sykorova A, Horacek J, Zak P et al (2005) A randomized, double blind comparative study of prophylactic parenteral nutritional support with or without glutamine in autologous stem cell transplantation for hematological malignancies – three years’ follow-up. Neoplasma 52:476–482PubMedGoogle Scholar
  33. 33.
    Tsujimoto T, Yamamoto Y, Wasa M et al (2015) L‑glutamine decreases the severity of mucositis induced by chemoradiotherapy inpatients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial. Oncol Rep 33(1):33–39PubMedGoogle Scholar
  34. 34.
    Vidal-Casariego A, Calleja-Fernandez A, Cano-Rodriguez I et al (2015) Effects of oral glutamine during abdominal radiotherapy on chronic radiationenteritis: a randomized controlled trial. Nutrition 31(1):200–204CrossRefPubMedGoogle Scholar
  35. 35.
    Vieira ML, Fonseca FL, Costa LG et al (2015) Supplementation with selenium can influence nausea, fatigue, physical, renal, and liver function of children and adolescents with cancer. J Med Food 18:109–117CrossRefPubMedGoogle Scholar
  36. 36.
    Villaseñor A, Ballard-Barbash R, Ambs A et al (2013) Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control 24(4):759–767CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Wagner D, Trudel D, Van der Kwast T et al (2013) Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients. J Clin Endocrinol Metab 98(4):1498–1507CrossRefPubMedGoogle Scholar
  38. 38.
    Waltman NL, Ott CD, Twiss JJ et al (2009) Vitamin D insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy. Cancer Nurs 32(2):143–150CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Zgaga L, Theodoratou E, Farrington SM et al (2014) Plasma Vitamin D Concentration Influences Survival Outcome After Diagnosis of Colorectal Cancer. J Clin Oncol 32(23):2430–2439CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • R. Mücke
    • 1
    • 2
    Email author
  • B. Zomorodbakhsch
    • 3
  • O. Micke
    • 4
  • J. Büntzel
    • 5
  • K. Kisters
    • 6
  • I. A. Adamietz
    • 2
  • K. Fakhrian
    • 2
  1. 1.Strahlentherapie RheinMainNaheBad KreuznachDeutschland
  2. 2.Klinik für Strahlentherapie und RadioonkologieRuhr-Universität BochumBochumDeutschland
  3. 3.Zentrum für Innere Medizin, Abteilung Hämatologie, Onkologie und PalliativmedizinHarzklinikum WernigerodeWernigerodeDeutschland
  4. 4.Klinik für Strahlentherapie und RadioonkologieFranziskus-Hospital BielefeldBielefeldDeutschland
  5. 5.Klinik für HNO-HeilkundeSüdharzklinikum NordhausenNordhausenDeutschland
  6. 6.Klinik für Innere MedizinSankt Anna Hospital HerneHerneDeutschland

Personalised recommendations